Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.42NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.42NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.568NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.568NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.568NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.13 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.13 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.13 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.372NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.372NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.372NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.634NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.634NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.634NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.37.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.37.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.37.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-17590.1China
B.1.630NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.630NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.630NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.360NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.360NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.360NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.578NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.578NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.578NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.544NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.544NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.544NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used